Literature DB >> 32997191

Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Boris Böll1, Enrico Schalk2, Dieter Buchheidt3, Justin Hasenkamp4, Michael Kiehl5, Til Ramon Kiderlen6, Matthias Kochanek7, Michael Koldehoff8, Philippe Kostrewa9, Annika Y Claßen7, Sibylle C Mellinghoff7, Bernd Metzner10, Olaf Penack11, Markus Ruhnke12, Maria J G T Vehreschild13, Florian Weissinger14, Hans-Heinrich Wolf15, Meinolf Karthaus16, Marcus Hentrich17.   

Abstract

Cancer patients frequently require central venous catheters for therapy and parenteral nutrition and are at high risk of central venous catheter-related infections (CRIs). Moreover, CRIs prolong hospitalization, cause an excess in resource utilization and treatment cost, often delay anti-cancer treatment, and are associated with a significant increase in mortality in cancer patients. We therefore summoned a panel of experts by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) and updated our previous guideline on CRIs in cancer patients. After conducting systematic literature searches on PubMed, Medline, and Cochrane databases, video- and meeting-based consensus discussions were held. In the presented guideline, we summarize recommendations on definition, diagnosis, management, and prevention of CRIs in cancer patients including the grading of strength of recommendations and the respective levels of evidence. This guideline supports clinicians and researchers alike in the evidence-based decision-making in the management of CRIs in cancer patients.

Entities:  

Keywords:  CLABSI; CRBSI; Cancer; Catheter infection; Central venous catheter; Neutropenia

Year:  2020        PMID: 32997191     DOI: 10.1007/s00277-020-04286-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  161 in total

1.  Guide to development of practice guidelines.

Authors:  M A Kish
Journal:  Clin Infect Dis       Date:  2001-03-09       Impact factor: 9.079

2.  Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients.

Authors:  H A Hanna; I Raad
Journal:  Infect Control Hosp Epidemiol       Date:  2001-03       Impact factor: 3.254

3.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

Review 4.  Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.

Authors:  Craig A Umscheid; Matthew D Mitchell; Jalpa A Doshi; Rajender Agarwal; Kendal Williams; Patrick J Brennan
Journal:  Infect Control Hosp Epidemiol       Date:  2011-02       Impact factor: 3.254

Review 5.  Advances in prevention and management of central line-associated bloodstream infections in patients with cancer.

Authors:  Issam Raad; Anne-Marie Chaftari
Journal:  Clin Infect Dis       Date:  2014-11-15       Impact factor: 9.079

6.  Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis.

Authors:  H Bouzidi; A Emirian; A Marty; E Chachaty; A Laplanche; B Gachot; F Blot
Journal:  J Hosp Infect       Date:  2018-02-10       Impact factor: 3.926

7.  Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Authors:  M Hentrich; E Schalk; M Schmidt-Hieber; I Chaberny; S Mousset; D Buchheidt; M Ruhnke; O Penack; H Salwender; H-H Wolf; M Christopeit; S Neumann; G Maschmeyer; M Karthaus
Journal:  Ann Oncol       Date:  2014-01-07       Impact factor: 32.976

8.  Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse.

Authors:  Hend Hanna; Claude Afif; Badie Alakech; Maha Boktour; Jeffrey Tarrand; Ray Hachem; Issam Raad
Journal:  Infect Control Hosp Epidemiol       Date:  2004-08       Impact factor: 3.254

Review 9.  Vascular access in oncology patients.

Authors:  Maurizio Gallieni; Mauro Pittiruti; Roberto Biffi
Journal:  CA Cancer J Clin       Date:  2008-10-29       Impact factor: 508.702

10.  Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study.

Authors:  Ioannis Chatzinikolaou; Hend Hanna; Ray Hachem; Badie Alakech; Jeffrey Tarrand; Issam Raad
Journal:  Diagn Microbiol Infect Dis       Date:  2004-11       Impact factor: 2.803

View more
  8 in total

1.  Real-World Data.

Authors:  Enrico Schalk; Marcus Hentrich
Journal:  Dtsch Arztebl Int       Date:  2022-02-25       Impact factor: 8.251

2.  Clinical and Microbiological Characteristics of Neonates with Candidemia and Impacts of Therapeutic Strategies on the Outcomes.

Authors:  Yu-Ning Chen; Jen-Fu Hsu; Shih-Ming Chu; Mei-Yin Lai; Chih Lin; Hsuan-Rong Huang; Peng-Hong Yang; Ming-Chou Chiang; Ming-Horng Tsai
Journal:  J Fungi (Basel)       Date:  2022-04-29

3.  Establishment of a Risk Prediction Model for Pulmonary Infection in Patients with Advanced Cancer.

Authors:  Liangliang Yang; Xiaolong Xu; Qingquan Liu
Journal:  Appl Bionics Biomech       Date:  2022-05-30       Impact factor: 1.664

4.  Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study.

Authors:  Hong Zhang; Yumei Li; Nannan Zhu; Yanfang Li; Jinqiu Fu; Jing Liu
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

5.  Pre-Procedure Thrombocytopenia and Leukopenia Association with Risk for Infection in Image-Guided Tunneled Central Venous Catheter Placement.

Authors:  Abigail Luman; Keith B Quencer; Claire Kaufman
Journal:  Tomography       Date:  2022-03-01

6.  Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.

Authors:  Jens Panse; Daniela Tölle; Eva Fiegle; Jan-Hendrik Naendrup; Martin Schmidt-Hieber; Boris Böll; Marcus Hentrich; Daniel Teschner; Enrico Schalk
Journal:  Ann Hematol       Date:  2022-08-17       Impact factor: 4.030

7.  Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic.

Authors:  Enrico Schalk; Timo Schmitt; Jens Panse; Eva Fiegle; Jan-Hendrik Naendrup; Martin Schmidt-Hieber; Boris Böll; Marcus Hentrich; Daniel Teschner; Dimitrios Mougiakakos
Journal:  Br J Haematol       Date:  2022-08-26       Impact factor: 8.615

Review 8.  Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.

Authors:  Ondřej Kubeček; Pavla Paterová; Martina Novosadová
Journal:  Life (Basel)       Date:  2021-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.